Table 2.
Demographics and Patient Characteristics of Participants in SRC with p value of Difference from SOC
| SRC, N=117 | SOC, N=117 | p value | Odds Ratio of Being in the SRC (95% CI) | p value | ||
|---|---|---|---|---|---|---|
| N (%) | N (%) | |||||
| Education | Intermediate to high education (high school, university and above) | 70 (47.6) | 77 (52.4) | 0.344 | 0.774 (0.455 – 1.316) | 0.344 |
| Smoking | Yes | 1 (6.3) | 15 (93.8) | <0.001* | 0.059 (0.008 – 0.452) | 0.006* |
| Average income in SR | High (>12,000 SR) | 26 (57.8) | 19 (42.2) | 0.246 | 1.474 (0.764 – 2.842) | 0.247 |
| Working | Yes | 32 (45.7) | 38 (54.3) | 0.392 | 0.783 (0.447 – 1.372) | 0.392 |
| Living situation | Alone | 6 (66.7) | 3 (33.3) | 0.499 | 2.054 (0.501 – 8.416) | 0.317 |
| Other comorbidities | Yes | 60 (56.6) | 46 (43.4) | 0.066 | 1.625 (0.967–2.729) | 0.067 |
| Number of comorbidities | >1 | 27 (36.5) | 47 (63.5) | 0.005* | 0.447 (0.253 – 0.788) | 0.005* |
| Early or established rheumatoid arthritis | Established (>2 years) | 115 (54.2) | 97 (45.8) | 0.001* | 11.856 (2.703 – 52.001) | 0.001* |
| Activation level 3 or 4 | Yes | 88 (60.7) | 57 (39.3) | <0.001* | 3.194 (1.835 – 5.562) | <0.001* |
| cDMARDs | Yes | 64 (40.5) | 94 (59.5) | <0.001* | 0.295 (0.165 – 0.530) | <0.001* |
| TNFi biologics | Yes | 30 (49.2) | 31 (50.8) | 0.882 | 0.957 (0.534 – 1.715) | 0.882 |
| Non-TNF biologics | Yes | 19 (57.6) | 14 (42.4) | 0.348 | 1.426 (0.678 – 3.001) | 0.349 |
| tsDMARDs | Yes | 54 (60.0) | 36 (40.0) | 0.016* | 1.929 (1.129 – 3.29) | 0.016* |
Note: *p<0.05.
Abbreviations: SRC, Specialized rheumatology clinics; SOC, slandered of care; cDMARDs, conventional disease-modifying antirheumatic drugs, TNFi, tumor necrosis factor inhibitors; tsDMARDs, targeted synthetic disease-modifying antirheumatic drugs; SR, Saudi Riyals.